Literature DB >> 21075148

Evidence for prenylation-dependent targeting of a Ykt6 SNARE in Plasmodium falciparum.

Lawrence Ayong1, Thiago DaSilva, Jennifer Mauser, Charles M Allen, Debopam Chakrabarti.   

Abstract

Ykt6 proteins are the most versatile fusogens in eukaryotic cells, and the only SNAREs that can be both prenylated and acylated at a C-terminal CAAX motif. Unlike yeast and mammalian cells where a single Ykt6 gene is expressed, the Plasmodium falciparum genome encodes two Ykt6 proteins. We have investigated the expression and prenylation of the Ykt6 orthologue, PfYkt6.1 in intra-erythrocytic stages of P. falciparum. PfYkt6.1 localized to the parasite Golgi and other unidentified cytoplasmic compartments, and was partly cytosolic (∼50% in early trophozoites). The membrane-association of PfYkt6.1 was dependent on the presence of a conserved C-terminal CAAX motif (CCSIM). By expressing full-length and mutant proteins in Escherichia coli, we have shown that PfYkt6.1 indeed serves as substrate for prenylation by P. falciparum farnesyltransferases. Surprisingly, PfYkt6.1 could also be geranylgeranylated by parasite extracts independent of the C-terminal amino acid residue. Deletion of the CAAX motif inhibited both farnesylation and geranylgeranylation activities. Additionally, the PfYkt6.1 heptapeptide KQCCSIM, corresponding to the C-terminal CAAX sequence, inhibited the parasite farnesyltransferase activity with an IC(50) of 1 μM. Our findings underscore the importance of CAAX motif-derived peptidomimetics for antimalarial drug development.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21075148      PMCID: PMC3030980          DOI: 10.1016/j.molbiopara.2010.11.007

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  54 in total

1.  Targeting of C-terminal (tail)-anchored proteins: understanding how cytoplasmic activities are anchored to intracellular membranes.

Authors:  B Wattenberg; T Lithgow
Journal:  Traffic       Date:  2001-01       Impact factor: 6.215

2.  Protein geranylgeranyltransferase of Saccharomyces cerevisiae is specific for Cys-Xaa-Xaa-Leu motif proteins and requires the CDC43 gene product but not the DPR1 gene product.

Authors:  A A Finegold; D I Johnson; C C Farnsworth; M H Gelb; S R Judd; J A Glomset; F Tamanoi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

Review 3.  Protein trafficking in Plasmodium falciparum-infected red blood cells.

Authors:  Brian M Cooke; Klaus Lingelbach; Lawrence H Bannister; Leann Tilley
Journal:  Trends Parasitol       Date:  2004-12

Review 4.  SNAREs--engines for membrane fusion.

Authors:  Reinhard Jahn; Richard H Scheller
Journal:  Nat Rev Mol Cell Biol       Date:  2006-08-16       Impact factor: 94.444

Review 5.  Prenyl proteins in eukaryotic cells: a new type of membrane anchor.

Authors:  J A Glomset; M H Gelb; C C Farnsworth
Journal:  Trends Biochem Sci       Date:  1990-04       Impact factor: 13.807

6.  Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes.

Authors:  J A Glomset; C C Farnsworth
Journal:  Annu Rev Cell Biol       Date:  1994

Review 7.  Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies.

Authors:  S M Sebti; A D Hamilton
Journal:  Oncogene       Date:  2000-12-27       Impact factor: 9.867

8.  Ykt6p is a multifunctional yeast R-SNARE that is required for multiple membrane transport pathways to the vacuole.

Authors:  Youngseok Kweon; Anca Rothe; Elizabeth Conibear; Tom H Stevens
Journal:  Mol Biol Cell       Date:  2003-01-26       Impact factor: 4.138

9.  Post-translational integration of tail-anchored proteins is facilitated by defined molecular chaperones.

Authors:  Benjamin M Abell; Catherine Rabu; Pawel Leznicki; Jason C Young; Stephen High
Journal:  J Cell Sci       Date:  2007-04-24       Impact factor: 5.285

10.  Towards complete sets of farnesylated and geranylgeranylated proteins.

Authors:  Sebastian Maurer-Stroh; Manfred Koranda; Wolfgang Benetka; Georg Schneider; Fernanda L Sirota; Frank Eisenhaber
Journal:  PLoS Comput Biol       Date:  2007-02-23       Impact factor: 4.475

View more
  8 in total

1.  The Prenylated Proteome of Plasmodium falciparum Reveals Pathogen-specific Prenylation Activity and Drug Mechanism-of-action.

Authors:  Jolyn E Gisselberg; Lichao Zhang; Joshua E Elias; Ellen Yeh
Journal:  Mol Cell Proteomics       Date:  2016-12-31       Impact factor: 5.911

2.  Isoprenoid metabolism in apicomplexan parasites.

Authors:  Leah Imlay; Audrey R Odom
Journal:  Curr Clin Microbiol Rep       Date:  2014-12-01

Review 3.  Isoprenoid biosynthesis in Plasmodium falciparum.

Authors:  Ann M Guggisberg; Rachel E Amthor; Audrey R Odom
Journal:  Eukaryot Cell       Date:  2014-09-12

4.  Cryptic organelle homology in apicomplexan parasites: insights from evolutionary cell biology.

Authors:  Christen M Klinger; R Ellen Nisbet; Dinkorma T Ouologuem; David S Roos; Joel B Dacks
Journal:  Curr Opin Microbiol       Date:  2013-08-08       Impact factor: 7.934

Review 5.  Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies.

Authors:  Isabelle Coppens
Journal:  Nat Rev Microbiol       Date:  2013-10-28       Impact factor: 60.633

6.  An essential farnesylated kinesin in Trypanosoma brucei.

Authors:  Erin J Engelson; Frederick S Buckner; Wesley C Van Voorhis
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

7.  Global proteomic analysis of prenylated proteins in Plasmodium falciparum using an alkyne-modified isoprenoid analogue.

Authors:  Kiall F Suazo; Chad Schaber; Charuta C Palsuledesai; Audrey R Odom John; Mark D Distefano
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

8.  ProtozoaDB 2.0: A Trypanosoma Brucei Case Study.

Authors:  Rodrigo Jardim; Diogo Tschoeke; Alberto M R Da Vila
Journal:  Pathogens       Date:  2017-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.